DK225689A - Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi - Google Patents

Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi Download PDF

Info

Publication number
DK225689A
DK225689A DK225689A DK225689A DK225689A DK 225689 A DK225689 A DK 225689A DK 225689 A DK225689 A DK 225689A DK 225689 A DK225689 A DK 225689A DK 225689 A DK225689 A DK 225689A
Authority
DK
Denmark
Prior art keywords
effect
metaloporphyrines
tumor therapy
toxic
therapy
Prior art date
Application number
DK225689A
Other languages
English (en)
Other versions
DK225689D0 (da
Inventor
Attallah Kappas
George S Drummond
Paul S Wissel
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of DK225689A publication Critical patent/DK225689A/da
Publication of DK225689D0 publication Critical patent/DK225689D0/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • C07H15/252—Naphthacene radicals, e.g. daunomycins, adriamycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK225689A 1987-09-08 1989-05-08 Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi DK225689D0 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9381787A 1987-09-08 1987-09-08
PCT/US1988/003052 WO1989002269A1 (en) 1987-09-08 1988-09-06 Use of metalloporphyrins to reverse the toxic effect of tumor therapy

Publications (2)

Publication Number Publication Date
DK225689A true DK225689A (da) 1989-05-08
DK225689D0 DK225689D0 (da) 1989-05-08

Family

ID=22240903

Family Applications (1)

Application Number Title Priority Date Filing Date
DK225689A DK225689D0 (da) 1987-09-08 1989-05-08 Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi

Country Status (10)

Country Link
EP (1) EP0333831B1 (da)
JP (1) JPH02501740A (da)
KR (1) KR890701108A (da)
AT (1) ATE78164T1 (da)
AU (1) AU603938B2 (da)
DE (1) DE3872871T2 (da)
DK (1) DK225689D0 (da)
ES (1) ES2012547A6 (da)
GR (1) GR1000117B (da)
WO (1) WO1989002269A1 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6245758B1 (en) 1994-05-13 2001-06-12 Michael K. Stern Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor
BR9507643A (pt) * 1994-05-13 1997-09-23 Monsanto Co Métodos de uso para catalisadores de decomposição de peroxinitrito composições farmacéuticas para os mesmos
GB9606293D0 (en) * 1996-03-26 1996-05-29 William Harvey Research Limite Treatment of cancers and other tumours
JP4743673B2 (ja) 1999-04-30 2011-08-10 プロゲン ファーマシューティカルズ， インコーポレイテッド ポリアミンおよび治療におけるそれらの使用
US7375216B2 (en) 2002-06-04 2008-05-20 Infacare Pharmaceutical Corporation Preparation of metal mesoporphyrin compounds
US7960371B2 (en) * 2006-10-04 2011-06-14 Infacare Pharmaceutical Corporation High-purity large-scale preparation of stannsoporfin
PL2691398T3 (pl) 2011-03-30 2017-07-31 Infacare Pharmaceutical Corporation Sposoby syntezy mezoporfiryn metali

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4386087A (en) * 1981-07-01 1983-05-31 Research Foundation Of The City University Of New York N-Substituted metalloporphyrins as anti-tumor agents against PS-P-388(P388) leukemia in animals
DE8506853U1 (de) * 1985-03-08 1985-10-10 Neumeier, Robert, 8183 Rottach-Egern Verschlußkopf eines aufblasbaren Luftballons
US4668670A (en) * 1986-06-20 1987-05-26 The Rockefeller University Tin diiododeuteroporphyrin and therapeutic use thereof
US4692439A (en) * 1986-06-20 1987-09-08 The Rockefeller University Therapeutic use of tin diiododeuteroporphyrin
US4782049A (en) * 1986-12-08 1988-11-01 The Rockefeller University Tin protoporphyrin and tin mesoporphyrin in the treatment of psoriasis

Also Published As

Publication number Publication date
EP0333831A4 (en) 1990-06-26
WO1989002269A1 (en) 1989-03-23
ATE78164T1 (de) 1992-08-15
AU603938B2 (en) 1990-11-29
GR880100589A (en) 1989-06-22
DE3872871D1 (de) 1992-08-20
EP0333831B1 (en) 1992-07-15
JPH02501740A (ja) 1990-06-14
ES2012547A6 (es) 1990-04-01
KR890701108A (ko) 1989-12-19
GR1000117B (el) 1991-06-28
DE3872871T2 (de) 1992-12-03
AU2525488A (en) 1989-04-17
DK225689D0 (da) 1989-05-08
EP0333831A1 (en) 1989-09-27

Similar Documents

Publication Publication Date Title
FI843930L (fi) Maerkta konjugat av metalltionein och maolsoekande biologiskt aktiva molekyler.
DE3587941D1 (de) Gerät zur vorläufigen reperfusionsbehandlung von herzanfallsymptomen.
KR890701107A (ko) 알쯔하이머 병 치료용 화합물들
ATE4168T1 (de) 2-phenyl-1,2-benzisoselenazol-3(2h)-one enthaltende pharmazeutische zubereitungen und ihre anwendung.
SE8000435L (sv) N-bensylimidazoler med selektivt inhiberande verkan pa tromboxansyntetasenzymet jemte farmaceutiska beredningar innehallande sadana n-bensylimidazoler och sett for deras framstellning
IT8027029A0 (it) Complessi platino-diamminici e formulazioni farmaceutiche per il trattamento del cancro che licontengono.
DE3774918D1 (de) Cancerostatisches mittel.
ATE87214T1 (de) Verwendung katabolischer enzyme zur herstellung eines medikaments zum bekaempfen der erworbenen immunschwaeche (aids) und deren vorstadien (las, arc).
DE69202441D1 (de) Melatoninderivate und Kombinationen mit Antiestrogenen zur Behandlung von Brustkarzinoma.
SE7905593L (sv) Acylderivat av karnitin och forfarande for framstellning derav
GB8824869D0 (en) Synthetic antibody
CY1105818T1 (el) Χρησεις του et743 στην θepαπευτικη αγωγη του καρκινου
DK47089D0 (da) Middel med oedelaeggende virkning paa maligne tumorer, fremgangsmaade til fremstilling af saadanne midler og anvendelse af disse til terapeutisk behandling af cancer
DK443088D0 (da) Praeparat til behandling af psoriasis
ATE188873T1 (de) Tris-platin-komplexe
DK225689D0 (da) Anvendelse af metalloporphyriner til modvirkning af den toksiske virkning af tumorterapi
DE3854121D1 (de) Arzneimittelzusammensetzungen zur behandlung von psoriasis.
DK277387D0 (da) Terapeutisk topikal sammensaetning mod en hyperprolifererende epithelsygdom
RU94039553A (ru) Средство для лечения хронического простатита
RU94024337A (ru) Антиметастатическое средство
DE3879709D1 (de) Platin-arzneimittel.
EP0301449A3 (en) Enantiomers of propafenone-containing therapeutic agents
DE3374066D1 (en) N-acyl derivatives of peptides, their manufacture and use in combating diseases and means therefor
DK0427633T3 (da) Anvendelse af et polypeptid med gammainterferonaktivitet til fremstilling af farmaceutiske præparater beregnet til behandling af primitiv pleuracancer
IT1232761B (it) Cura chimica del cancro del castagno mediante iniezione o per via corticale

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment